congenital toxoplasmosis
MeSH: D014125ORPHA: 8582 Treatments Available
Overview
toxoplasmosis that involves a reactivated infection of the mother transmitted to the fetus during pregnancy
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Pyrimethamine Orphan | Tablet | FDA Approved | 1 | — |
| Sulfadiazine | Tablet | FDA Approved | 1 | — |
Clinical Presentation
Signs and symptoms associated with congenital toxoplasmosis, sourced from HPO and Orphanet clinical annotations.
HydrocephalusMicrocephalyHearing impairmentVisual impairmentMicrophthalmiaNystagmusJaundiceSeizureHypotoniaGlobal developmental delayIntrauterine growth retardationFailure to thrive in infancyAscitesPremature birthCardiomegalyThrombocytopeniaAnemiaDiarrheaVentriculomegalyHepatomegalyCerebral calcificationLymphadenopathyElevated circulating hepatic transaminase concentrationAbnormal retinal pigmentationMaculeCognitive impairment
Classification & Codes
MeSH Code
D014125Orphanet Code
ORPHA:858congenital toxoplasmosis
| MeSH | D014125 |
| Orphanet | ORPHA:858 |
| Treatments | 2 drug(s) |
| Symptoms on record | 26 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO